Life Sciences

Five Fatal Flaws in Rep. Katie Porter’s Indictment of the U.S. Drug Industry
In her sensationally titled report, “Killer Profits: How Big Pharma Takeovers Destroy Innovation and Harm Patients,” the deputy chair of the Congressional Progressive Caucus issued an ideologically inspired jeremiad grounded in assertions that are easily refuted with data.
Read More >>
Life Sciences
Check a box to narrow search for individual content items that cover numerous issues.
October 7, 2021
Pursuing an ITA-3 to Bolster Global Economic Growth and Opportunity
Please join ITIF and the Semiconductor Industry Association (SIA) for a webinar releasing a new report showing how ITA-3 expansion can bring significant benefits to global and individual economies alike.
August 16, 2021
Fact of the Week: The Pharmaceutical Industry Invested $83 Billion on R&D in 2019, a Tenfold Increase Since the 1980s
This growth comes with real-world improvements to patient outcomes. The decade from 2010 through 2019 saw a 60 percent increase in new drug approvals compared to the previous decade.
June 16, 2021
Biden Officials Discuss White House Supply Chain Report
ITIF hosted an in-depth discussion with members of the Biden Administration about the report, implications for policy, and potential next steps.
May 20, 2021
Five Fatal Flaws in Rep. Katie Porter’s Indictment of the U.S. Drug Industry
In her sensationally titled report, “Killer Profits: How Big Pharma Takeovers Destroy Innovation and Harm Patients,” the deputy chair of the Congressional Progressive Caucus issued an ideologically inspired jeremiad grounded in assertions that are easily refuted with data.
May 10, 2021
COVID-19 Vaccine Patent Waivers Won’t Solve the Problem
Those who really want to solve the problem should abandon ill-advised proposals like patent waivers and focus instead on cooperative solutions to overcoming supply-chain constraints. The sooner that happens, the sooner we can all breathe freely again.
April 29, 2021
How Intellectual Property Has Played a Pivotal Role in the Global COVID-19 Response
ITIF hosted an expert panel discussion about the report and the vital role IP has played throughout the pandemic.
April 29, 2021
Ten Ways IP Has Enabled Innovations That Have Helped Sustain the World Through the Pandemic
From vaccines and therapeutics to delivery robots, intellectual property has played an indispensable role in facilitating development of a range of inventive products that have helped address health care, work, and social challenges brought on by the pandemic.
April 21, 2021
Seizing the Transformative Opportunity of Multi-cancer Early Detection
ITIF hosted an expert panel discussion exploring the groundbreaking innovations and policy considerations impacting the field of multi-cancer early detection.
April 20, 2021
Will Productivity and Growth Return After the COVID-19 Crisis?
ITIF hosted an expert panel discussion to explore the economic, health, and social effects that may persist post-COVID.
April 19, 2021
Seizing the Transformative Opportunity of Multi-cancer Early Detection
Blood-based multi-cancer early detection (MCED) technologies hold the promise to revolutionize America’s cancer-screening paradigm, dramatically expanding the range of detectable cancers and identifying them at earlier stages when cancers are more treatable. Policymakers should provide a supportive regulatory and coverage environment.

Pages